North America Large Molecule Bioanalytical Testing Services Market Size, Share & Industry Trends Analysis Report By End-user (SMEs and Large Firms), By Test Type, By Type (ADA, Pharmacokinetics), By Phase, By Therapeutic Areas, By Country and Growth Forecast, 2022 - 2028

The North America Large Molecule Bioanalytical Testing Services Market would witness market growth of 8.1% CAGR during the forecast period (2022-2028).

When the term "ADME/PK screening" is used, it refers to in vitro methods of examining absorption and metabolism. Prior to the period of clinical investigations, drug metabolism studies were carried out at a late stage of the drug development process. Consequently, insufficient metabolism and PK parameters were the primary cause of NCE failure.

Additionally, it is projected that rising government measures to stop the spread of infectious diseases like Corona and the Ebola virus would expand market potential. The research efforts and the existence of a sizable pipeline of compounds based on biologics, peptides, and amino acids, biologics has been increased. The bioanalysis of big molecules calls for qualified experts and cutting-edge infrastructure and analytical tools. These services are easily accessible from providers of bioanalytical testing services.

The budgetary health of the US government is significantly impacted by rising healthcare spending. The burden placed on the populace to support this spending, such as raising taxes or increasing long-term borrowing, is the main effect of the growth in the government's portion of health care spending. Tax hikes not only reduce the amount of money that businesses and individuals would have for other uses, but they also encourage people to take actions to mitigate their consequences.

The US market dominated the North America Large Molecule Bioanalytical Testing Services Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $881.1 million by 2028. The Canada market is experiencing a CAGR of 10.6% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 9.6% during (2022 - 2028).

Based on End-user, the market is segmented into SMEs and Large Firms. Based on Test Type, the market is segmented into Bioavailability, ADME, PD, Bioequivalence, and Others. Based on Type, the market is segmented into ADA, Pharmacokinetics, and Others. Based on Phase, the market is segmented into Clinical and Pre-clinical (With Antibody and Without Antibody (ELISA Based Assay)). Based on Therapeutic Areas, the market is segmented into Oncology, Neurology, Infectious Diseases, Cardiology, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Free Valuable Insights: The Global Large Molecule Bioanalytical Testing Services Market is Predict to reach $2.8 Billion by 2028, at a CAGR of 9.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Laboratory Corporation Of America Holdings, IQVIA Holdings, Inc., Syneos Health, Inc., SGS S.A., Intertek Group PLC, Pace Analytical Services, LLC, ICON Plc, Charles River Laboratories International, Inc., and Thermo Fisher Scientific, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End-user

• SMEs
• Large Firms

By Test Type

• Bioavailability
• ADME
• PD
• Bioequivalence
• Others

By Type

• ADA
• Pharmacokinetics
• Others

By Phase

• Clinical
• Pre-clinical
  • With Antibody
  • Without Antibody (ELISA Based Assay)

By Therapeutic Areas

• Oncology
• Neurology
• Infectious Diseases
• Cardiology
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Laboratory Corporation Of America Holdings
• IQVIA Holdings, Inc.
• Syneos Health, Inc.
• SGS S.A.
• Intertek Group PLC
• Pace Analytical Services, LLC
• ICON Plc
• Charles River Laboratories International, Inc.
• Thermo Fisher Scientific, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Large Molecule Bioanalytical Testing Services Market, by End-user
1.4.2 North America Large Molecule Bioanalytical Testing Services Market, by Test Type
1.4.3 North America Large Molecule Bioanalytical Testing Services Market, by Type
1.4.4 North America Large Molecule Bioanalytical Testing Services Market, by Phase
1.4.5 North America Large Molecule Bioanalytical Testing Services Market, by Therapeutic Areas
1.4.6 North America Large Molecule Bioanalytical Testing Services Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Large Molecule Bioanalytical Testing Services Market

Chapter 4. North America Large Molecule Bioanalytical Testing Services Market by End-user
4.1 North America SMEs Market by Country
4.2 North America Large Firms Market by Country

Chapter 5. North America Large Molecule Bioanalytical Testing Services Market by Test Type
5.1 North America Bioavailability Market by Country
5.2 North America ADME Market by Country
5.3 North America PD Market by Country
5.4 North America Bioequivalence Market by Country
5.5 North America Others Market by Country

Chapter 6. North America Large Molecule Bioanalytical Testing Services Market by Type
6.1 North America ADA Market by Country
6.2 North America Pharmacokinetics Market by Country
6.3 North America Others Market by Country

Chapter 7. North America Large Molecule Bioanalytical Testing Services Market by Phase
7.1 North America Clinical Market by Country
7.2 North America Pre-clinical Market by Country
7.3 North America Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
7.3.1 North America With Antibody Market by Country
7.3.2 North America Without Antibody (ELISA Based Assay) Market by Country

Chapter 8. North America Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
8.1 North America Oncology Market by Country
8.2 North America Neurology Market by Country
8.3 North America Infectious Diseases Market by Country
8.4 North America Cardiology Market by Country
8.5 North America Others Market by Country

Chapter 9. North America Large Molecule Bioanalytical Testing Services Market by Country
9.1 US Large Molecule Bioanalytical Testing Services Market
9.1.1 US Large Molecule Bioanalytical Testing Services Market by End-user
9.1.2 US Large Molecule Bioanalytical Testing Services Market by Test Type
9.1.3 US Large Molecule Bioanalytical Testing Services Market by Type
9.1.4 US Large Molecule Bioanalytical Testing Services Market by Phase
9.1.4.1 US Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.1.5 US Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.2 Canada Large Molecule Bioanalytical Testing Services Market
9.2.1 Canada Large Molecule Bioanalytical Testing Services Market by End-user
9.2.2 Canada Large Molecule Bioanalytical Testing Services Market by Test Type
9.2.3 Canada Large Molecule Bioanalytical Testing Services Market by Type
9.2.4 Canada Large Molecule Bioanalytical Testing Services Market by Phase
9.2.4.1 Canada Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.2.5 Canada Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.3 Mexico Large Molecule Bioanalytical Testing Services Market
9.3.1 Mexico Large Molecule Bioanalytical Testing Services Market by End-user
9.3.2 Mexico Large Molecule Bioanalytical Testing Services Market by Test Type
9.3.3 Mexico Large Molecule Bioanalytical Testing Services Market by Type
9.3.4 Mexico Large Molecule Bioanalytical Testing Services Market by Phase
9.3.4.1 Mexico Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.3.5 Mexico Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas
9.4 Rest of North America Large Molecule Bioanalytical Testing Services Market
9.4.1 Rest of North America Large Molecule Bioanalytical Testing Services Market by End-user
9.4.2 Rest of North America Large Molecule Bioanalytical Testing Services Market by Test Type
9.4.3 Rest of North America Large Molecule Bioanalytical Testing Services Market by Type
9.4.4 Rest of North America Large Molecule Bioanalytical Testing Services Market by Phase
9.4.4.1 Rest of North America Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type
9.4.5 Rest of North America Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas

Chapter 10. Company Profiles
10.1 IQVIA Holdings, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Recent strategies and developments:
10.1.4.1 Product Launches and Product Expansions:
10.1.4.2 Geographical Expansions:
10.2 SGS S.A.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Geographical Expansions:
10.3 Intertek Group PLC
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.4 ICON plc
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Recent strategies and developments:
10.4.4.1 Acquisition and Mergers:
10.5 Charles River Laboratories International, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Recent strategies and developments:
10.5.4.1 Acquisition and Mergers:
10.6 Thermo Fisher Scientific, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.7 Syneos Health, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.8 Laboratory Corporation Of America Holdings
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Recent strategies and developments:
10.8.4.1 Geographical Expansions:
10.9 Pace Analytical Services, LLC
10.9.1 Company Overview

TABLE 1 North America Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 2 North America Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 3 North America Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 4 North America Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 5 North America SMEs Market by Country, 2018 - 2021, USD Million
TABLE 6 North America SMEs Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Large Firms Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Large Firms Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 10 North America Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 11 North America Bioavailability Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Bioavailability Market by Country, 2022 - 2028, USD Million
TABLE 13 North America ADME Market by Country, 2018 - 2021, USD Million
TABLE 14 North America ADME Market by Country, 2022 - 2028, USD Million
TABLE 15 North America PD Market by Country, 2018 - 2021, USD Million
TABLE 16 North America PD Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Bioequivalence Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Bioequivalence Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 22 North America Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 23 North America ADA Market by Country, 2018 - 2021, USD Million
TABLE 24 North America ADA Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Pharmacokinetics Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Pharmacokinetics Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 30 North America Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 31 North America Clinical Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Clinical Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Pre-clinical Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Pre-clinical Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 36 North America Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 37 North America With Antibody Market by Country, 2018 - 2021, USD Million
TABLE 38 North America With Antibody Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Without Antibody (ELISA Based Assay) Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Without Antibody (ELISA Based Assay) Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 42 North America Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 43 North America Oncology Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Oncology Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Neurology Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Neurology Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Infectious Diseases Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Infectious Diseases Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Cardiology Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Cardiology Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Large Molecule Bioanalytical Testing Services Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Large Molecule Bioanalytical Testing Services Market by Country, 2022 - 2028, USD Million
TABLE 55 US Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 56 US Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 57 US Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 58 US Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 59 US Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 60 US Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 61 US Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 62 US Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 63 US Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 64 US Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 65 US Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 66 US Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 67 US Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 68 US Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 69 Canada Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 70 Canada Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 71 Canada Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 72 Canada Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 73 Canada Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 74 Canada Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 75 Canada Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 76 Canada Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 77 Canada Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 78 Canada Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 79 Canada Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 80 Canada Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 81 Canada Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 82 Canada Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 83 Mexico Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 84 Mexico Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 85 Mexico Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 86 Mexico Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 87 Mexico Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 88 Mexico Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 89 Mexico Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 90 Mexico Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 91 Mexico Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 92 Mexico Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 93 Mexico Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 94 Mexico Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 95 Mexico Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 96 Mexico Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 97 Rest of North America Large Molecule Bioanalytical Testing Services Market, 2018 - 2021, USD Million
TABLE 98 Rest of North America Large Molecule Bioanalytical Testing Services Market, 2022 - 2028, USD Million
TABLE 99 Rest of North America Large Molecule Bioanalytical Testing Services Market by End-user, 2018 - 2021, USD Million
TABLE 100 Rest of North America Large Molecule Bioanalytical Testing Services Market by End-user, 2022 - 2028, USD Million
TABLE 101 Rest of North America Large Molecule Bioanalytical Testing Services Market by Test Type, 2018 - 2021, USD Million
TABLE 102 Rest of North America Large Molecule Bioanalytical Testing Services Market by Test Type, 2022 - 2028, USD Million
TABLE 103 Rest of North America Large Molecule Bioanalytical Testing Services Market by Type, 2018 - 2021, USD Million
TABLE 104 Rest of North America Large Molecule Bioanalytical Testing Services Market by Type, 2022 - 2028, USD Million
TABLE 105 Rest of North America Large Molecule Bioanalytical Testing Services Market by Phase, 2018 - 2021, USD Million
TABLE 106 Rest of North America Large Molecule Bioanalytical Testing Services Market by Phase, 2022 - 2028, USD Million
TABLE 107 Rest of North America Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2018 - 2021, USD Million
TABLE 108 Rest of North America Large Molecule Bioanalytical Testing Services Market by Pre-clinical Type, 2022 - 2028, USD Million
TABLE 109 Rest of North America Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2018 - 2021, USD Million
TABLE 110 Rest of North America Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas, 2022 - 2028, USD Million
TABLE 111 Key information – IQVIA Holdings, Inc.
TABLE 112 Key Information – SGS S.A.
TABLE 113 Key Information – Intertek Group PLC
TABLE 114 Key Information – ICON PLC
TABLE 115 key information – Charles River Laboratories International, Inc.
TABLE 116 Key Information – Thermo Fisher Scientific, Inc.
TABLE 117 Key Information – Syneos Health, Inc.
TABLE 118 Key Information – Laboratory Corporation Of America Holdings
TABLE 119 Key Information – Pace Analytical Services, LLC

List of Figures
FIG 1 Methodology for the research